ZERONA® utilizes the Erchonia® Laser Scanner, the safest and most researched low-level laser in the world. Initially designed and FDA-cleared for use during liposuction, the non-invasive Erchonia® laser is applied to emulsify the adipose tissue and release excess fat into the interstitial space. From there, fat is passed through the body during its normal course of detoxification.
Whether performing traditional liposuction procedures or following the new ZERONA® protocol, certified experts can be confident they are treating their patients with the safest and most researched low level laser in the world.
The ZERONA® procedure has been proven through a double-blind, randomized, multi-site and placebo-controlled clinical study in which patients lost on average of 5 inches in waist, hip, thigh and arm circumference combined in 2 weeks. These results were dramatic compared to the placebo group, which only lost an average of half an inch over the same time period.
This animation shows:
The remarkable images above demonstrate the low-level laser's ability to emulsify adipose tissue. The pictures highlight the safe collapse of the rigid adipose cell and the secretion of triglycerides and fatty acid from the cell.
These images show the formation of a transitory pore forming in the bi-lipid membrane of an adipose cell. This pore is the direct result of safe, low-level laser stimulation and the reason why the triglycerides and fatty acids are able to move into the interstitial space. The tiny pore causes no damage to the cell. It simply allows the fatty content to safely evacuate the cell.
The ZERONA® process is well supported by scientific research and analysis. The specification configurations for ZERONA® are:
The use of low levels of visible or near-infrared (NIR) light for reducing pain, inflammation and edema, promoting healing of wounds, deeper tissues and nerves, and preventing tissue damage has been known for almost forty years since the invention of lasers.
A Randomized, Controlled Study Lasers in Surgery Medicine 41: 799-809 (2009)
One of the leaders in the advancement of cosmetic surgery practices, explains how the ZERONA® device and the non-invasive ZERONA® treatments are revolutionizing aesthetic protocols.
Erchonia study abstract presented at Society for Laser Medicine and Surgery Annual Conference demonstrating ZERONA's impact on reducing low-density lipoprotein levels (LDL).